Hosted on MSN12h
Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?
Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?
Every 100 Years America Produces a Robert Kennedy Jr.
It is impossible to read about Mr. Macfadden — who was using the term “medical freedom” in 1920 — without thinking about ...
Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Moderna outlines $1.5B-$2.5B 2025 revenue target with focus on 10 product approvals
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
STAT4d
The view from overseas on tumult in U.S. science
Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today ...
Investor's Business Daily on MSN4d
Moderna Stock Reverses As CEO Stephane Bancel Deflects Concerns Over RFK Jr.
Covid vaccine maker Moderna posted a mixed fourth-quarter report Friday as sales topped Wall Street's projections, but on ...
Moderna beats on revenue but loses more than expected as it scales down manufacturing
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.
New Republic5dOpinion
Only One Republican Was Brave Enough to Vote Against RFK Jr.
The country is about to get a lot sicker now that Robert F. Kennedy Jr. is head of the Health and Human Services Department.
RFK Jr. on glidepath to become HHS secretary after clearing first Senate vote
The Senate voted Wednesday to advance Robert F. Kennedy Jr. to be President Donald Trump’s health and human services secretary, teeing him up for confirmation Thursday morning. The GOP-controlled cham ...